Girl’s undisclosed death in gene-editing trial raises red flags in booming Chinese industry

Beijing —  A top Chinese medical university is investigating the death of a young girl in an experimental gene-editing trial conducted by a leading expert at its affiliated hospital that has raised serious concerns about ethics in China’s booming biomedical industry. Shanghai Jiaotong University School of Medicine said

Neither Hamas nor the Israeli government has issued an official statement acknowledging the deal, raising concerns about their eagerness to implement its clauses.

Girl’s undisclosed death in gene-editing trial raises red flags in booming Chinese industry  cnn.com

Suffering from a non-lethal disease, the child underwent experimental gene therapy in 2025, according to an investigation by the journal 'Science.'

The death of a six-year-old girl after receiving an experimental gene-editing therapy has been described by scientists as a tragedy that highlights the need to improve trial safeguards. But some in the biotechnology industry fear Chinese policymakers may curtail the regulatory flexibility that scientists have long enjo